Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
Sponsor: ReliantHeart Inc.
Terminated
Inability to timely enroll.
This NA trial investigates Cardiac Failure and Congestive Heart Failure and is currently terminated or withdrawn. ReliantHeart Inc. leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Aug 2018 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ReliantHeart Inc.
For direct contact, visit the study record on ClinicalTrials.gov .